Comparative pharmacokinetics, pharmacodynamics, efficacy and safety of two asparaginase preparations in children with previously untreated acute lymphoblastic leukemia (ALL).

Trial Profile

Comparative pharmacokinetics, pharmacodynamics, efficacy and safety of two asparaginase preparations in children with previously untreated acute lymphoblastic leukemia (ALL).

Completed
Phase of Trial: Phase II

Latest Information Update: 10 Sep 2009

At a glance

  • Drugs Asparaginase (Primary)
  • Indications Acute lymphoblastic leukaemia
  • Focus Pharmacokinetics
  • Most Recent Events

    • 16 May 2009 Additional lead trial centre identified as reported by Netherlands Trial Register.
    • 16 May 2009 New source identified and integrated (Netherlands Trial Register, record no. NTR402).
    • 06 Mar 2009 Status changed from not stated to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top